Lingling Yuan

645 citations
32 papers · 431 indexed · h-index 12
Topics
RNA modifications and cancer (10 papers)MicroRNA in disease regulation (5 papers)Cancer-related molecular mechanisms research (5 papers)
Partner nations
ChinaUnited StatesItaly

In The Last Decade

Lingling Yuan

30 papers receiving 430 citations

Peers

Lingling Yuan
Comparison fields: 5 of 84
  • Molecular Biology 234
  • Cancer Research 136
  • Pulmonary and Respiratory Medicine 76
  • Oncology 63
  • Epidemiology 51
Replace Xiuchao Geng with:
Xiuchao Geng China
Wei Qi China
Zhaomu Zeng China
Nassiba Taib Qatar
Yongbo An China
Lobna Al-Zaidan Qatar
Guiji Zhang China
Tareq Hossan Bangladesh
Lei Yuan China
Zhijie Feng China
Lingling Yuan relative to Xiuchao Geng China Xiuchao Geng's profile →
Citations per field
00.5×1.5×1.8×
Xiuchao Geng · 1×
Citations per year

Countries citing papers authored by Lingling Yuan

Since Specialization
Citations

This map shows the geographic impact of Lingling Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingling Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingling Yuan more than expected).

Fields of papers citing papers by Lingling Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingling Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingling Yuan. The network helps show where Lingling Yuan may publish in the future.

Co-authorship network of co-authors of Lingling Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Lingling Yuan. A scholar is included among the top collaborators of Lingling Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingling Yuan. Lingling Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 3
4 4
5 18
6 4
7 5
8 10
9 0
10 10
11 9
12 94
13 12
14 33
15 30
16 24
17 22
18 11
19 11
20 33

About Lingling Yuan

Lingling Yuan is a scholar working on Cancer Research, General Social Sciences and Toxicology, having authored 32 papers that have together received 431 indexed citations. Recurring topics across this work include RNA modifications and cancer (10 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Cancer Research (136 citations), Modeling and Simulation (29 citations) and Molecular Biology (234 citations). Lingling Yuan has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Zhi‐Jun Pei, Xu‐Sheng Liu, Yan Gao, Xiaoyu Liu, Minzi Deng, Jingjing Zhou, Weizhi Zhang, Jieqiong Tan, Fen Yang and Yinan Zheng. Their work appears in journals such as Frontiers in Immunology, Experimental Cell Research and European Journal of Nuclear Medicine and Molecular Imaging.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026